London
· Delayed Price · Currency is GBP · Price in EUR Clínica Baviera Statistics
Total Valuation
Clínica Baviera has a market cap or net worth of GBP 436.69 million. The enterprise value is 462.52 million.
| Market Cap | 436.69M |
| Enterprise Value | 462.52M |
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | Jul 16, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -1.94% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.07M |
Valuation Ratios
The trailing PE ratio is 14.15.
| PE Ratio | 14.15 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 11.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.76, with an EV/FCF ratio of 15.28.
| EV / Earnings | 14.99 |
| EV / Sales | 2.17 |
| EV / EBITDA | 7.76 |
| EV / EBIT | 10.66 |
| EV / FCF | 15.28 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.72.
| Current Ratio | 0.80 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 0.87 |
| Debt / FCF | 1.69 |
| Interest Coverage | 184.21 |
Financial Efficiency
Return on equity (ROE) is 45.36% and return on invested capital (ROIC) is 23.34%.
| Return on Equity (ROE) | 45.36% |
| Return on Assets (ROA) | 16.98% |
| Return on Capital (ROIC) | 23.34% |
| Revenue Per Employee | 120,742 |
| Profits Per Employee | 17,731 |
| Employee Count | 1,254 |
| Asset Turnover | 1.34 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.80% in the last 52 weeks. The beta is 0.55, so Clínica Baviera's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +29.80% |
| 50-Day Moving Average | 33.20 |
| 200-Day Moving Average | 31.39 |
| Relative Strength Index (RSI) | 40.61 |
| Average Volume (20 Days) | 40 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Clínica Baviera had revenue of GBP 210.09 million and earned 30.85 million in profits. Earnings per share was 1.93.
| Revenue | 210.09M |
| Gross Profit | 96.50M |
| Operating Income | 42.71M |
| Pretax Income | 43.23M |
| Net Income | 30.85M |
| EBITDA | 58.66M |
| EBIT | 42.71M |
| Earnings Per Share (EPS) | 1.93 |
Balance Sheet
The company has 26.86 million in cash and 51.19 million in debt, giving a net cash position of -24.33 million.
| Cash & Cash Equivalents | 26.86M |
| Total Debt | 51.19M |
| Net Cash | -24.33M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 70.82M |
| Book Value Per Share | 4.36 |
| Working Capital | -8.68M |
Cash Flow
In the last 12 months, operating cash flow was 52.46 million and capital expenditures -22.19 million, giving a free cash flow of 30.26 million.
| Operating Cash Flow | 52.46M |
| Capital Expenditures | -22.19M |
| Free Cash Flow | 30.26M |
| FCF Per Share | n/a |
Margins
Gross margin is 45.93%, with operating and profit margins of 20.33% and 14.68%.
| Gross Margin | 45.93% |
| Operating Margin | 20.33% |
| Pretax Margin | 20.58% |
| Profit Margin | 14.68% |
| EBITDA Margin | 27.92% |
| EBIT Margin | 20.33% |
| FCF Margin | 14.41% |
Dividends & Yields
Clínica Baviera does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | 18.03% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 67.91% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 7.06% |
| FCF Yield | 6.93% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |